7l8j: Difference between revisions

From Proteopedia
Jump to navigationJump to search
OCA (talk | contribs)
m Protected "7l8j" [edit=sysop:move=sysop]
OCA (talk | contribs)
No edit summary
 
(4 intermediate revisions by the same user not shown)
Line 1: Line 1:
'''Unreleased structure'''


The entry 7l8j is ON HOLD
==SARS-CoV-2 Main Protease (Mpro) in Complex with Rupintrivir (P21212)==
<StructureSection load='7l8j' size='340' side='right'caption='[[7l8j]], [[Resolution|resolution]] 2.45&Aring;' scene=''>
== Structural highlights ==
<table><tr><td colspan='2'>Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=7L8J OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=7L8J FirstGlance]. <br>
</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2.45&#8491;</td></tr>
<tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=AG7:4-{2-(4-FLUORO-BENZYL)-6-METHYL-5-[(5-METHYL-ISOXAZOLE-3-CARBONYL)-AMINO]-4-OXO-HEPTANOYLAMINO}-5-(2-OXO-PYRROLIDIN-3-YL)-PENTANOIC+ACID+ETHYL+ESTER'>AG7</scene></td></tr>
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=7l8j FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=7l8j OCA], [https://pdbe.org/7l8j PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=7l8j RCSB], [https://www.ebi.ac.uk/pdbsum/7l8j PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=7l8j ProSAT]</span></td></tr>
</table>
<div style="background-color:#fffaf0;">
== Publication Abstract from PubMed ==
Rupintrivir targets the 3C cysteine proteases of the picornaviridae family, which includes rhinoviruses and enteroviruses that cause a range of human diseases. Despite being a pan-3C protease inhibitor, rupintrivir activity is extremely weak against the homologous 3C-like protease of SARS-CoV-2. In this study, the crystal structures of rupintrivir were determined bound to enterovirus 68 (EV68) 3C protease and the 3C-like main protease (M(pro)) from SARS-CoV-2. While the EV68 3C protease-rupintrivir structure was similar to previously determined complexes with other picornavirus 3C proteases, rupintrivir bound in a unique conformation to the active site of SARS-CoV-2 M(pro) splitting the catalytic cysteine and histidine residues. This bifurcation of the catalytic dyad may provide a novel approach for inhibiting cysteine proteases.


Authors: Lockbaum, G.J., Henes, M., Lee, J.M., Timm, J., Nalivaika, E.A., Yilmaz, N.K., Thompson, P.R., Schiffer, C.A.
Pan-3C Protease Inhibitor Rupintrivir Binds SARS-CoV-2 Main Protease in a Unique Binding Mode.,Lockbaum GJ, Henes M, Lee JM, Timm J, Nalivaika EA, Thompson PR, Kurt Yilmaz N, Schiffer CA Biochemistry. 2021 Sep 10. doi: 10.1021/acs.biochem.1c00414. PMID:34506130<ref>PMID:34506130</ref>


Description: SARS-CoV-2 Main Protease (Mpro) in Complex with Rupintrivir (P21212)
From MEDLINE&reg;/PubMed&reg;, a database of the U.S. National Library of Medicine.<br>
[[Category: Unreleased Structures]]
</div>
[[Category: Timm, J]]
<div class="pdbe-citations 7l8j" style="background-color:#fffaf0;"></div>
[[Category: Henes, M]]
== References ==
[[Category: Yilmaz, N.K]]
<references/>
[[Category: Lockbaum, G.J]]
__TOC__
[[Category: Schiffer, C.A]]
</StructureSection>
[[Category: Lee, J.M]]
[[Category: Large Structures]]
[[Category: Nalivaika, E.A]]
[[Category: Henes M]]
[[Category: Thompson, P.R]]
[[Category: Lee JM]]
[[Category: Lockbaum GJ]]
[[Category: Nalivaika EA]]
[[Category: Schiffer CA]]
[[Category: Thompson PR]]
[[Category: Timm J]]
[[Category: Yilmaz NK]]

Latest revision as of 09:27, 9 October 2024

SARS-CoV-2 Main Protease (Mpro) in Complex with Rupintrivir (P21212)

7l8j, resolution 2.45Å

Drag the structure with the mouse to rotate

Proteopedia Page Contributors and Editors (what is this?)

OCA